M&A Deal Summary

Heska Acquires Biotech Laboratories

On September 9, 2021, Heska acquired life science company Biotech Laboratories

Acquisition Highlights
  • This is Heska’s 1st transaction in the Life Science sector.
  • This is Heska’s 4th transaction in the United States.
  • This is Heska’s 1st transaction in Maryland.

M&A Deal Summary

Date 2021-09-09
Target Biotech Laboratories
Sector Life Science
Buyer(s) Heska
Deal Type Add-on Acquisition

Target

Biotech Laboratories

Rockville, Maryland, United States
website
Biotech Laboratories develops a full line of rapid point-of-care tests to detect antigens and antibodies associated with infectious and parasitic diseases of animals. Biotech is led by a team of scientists and industry experts with over 100 collective years of disease diagnostic research, development, and operations. Biotech lateral flow tests are fast, accurate, and convenient; the products boast excellent specificity, sensitivity, and consistency, as well as mobile reader, extended shelf life, and easy storage capabilities. With a steadfast commitment to innovation and clinical research and development, the company aims to support healthier animals by providing high-quality diagnostic solutions to veterinarians, livestock producers, and pet owners worldwide. Biotech Laboratories was formed in 2016 and is based in Rockville, Maryland.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Heska

Loveland, Colorado, United States

website


Category Company
Founded 1988
Sector Medical Products
Employees808
Revenue 257M USD (2022)
DESCRIPTION

Heska sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. The company's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products and digital cytology services; local and cloud-based data services; practice information management software (“PIMS”) and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska’s primary focus is supporting companion animal veterinarians in providing care to their patients. Its business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada, and Mexico. International consists of geographies outside of North America, primarily in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. Heska’s strategic focus on point-of-care diagnostic laboratory products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the international segment includes PIMS business and veterinary laboratories. Heska was founded in 1988 and is based in Loveland, Colorado.


DEAL STATS #
Overall 6 of 8
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 4 of 6
State (Maryland) 1 of 1
Country (United States) 4 of 5
Year (2021) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-13 Lacuna Diagnostics

Fort Collins, Colorado, United States

Lacuna Diagnostics, Inc. is a digital telemedicine cytology platform that increases the standard of care veterinarians provide for pets by providing nearly real-time interpretation of cases by an expert network of board-certified clinical pathologists. Lacuna Diagnostics was founded in 2016 and headquartered in Fort Collins, Colorado.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-02 VetZ

Isernhagen, Germany

VetZ is a provider of veterinary practice information management software solutions ("PIMS"). VetZ offers easy-to-use and fully integrated software solutions for better workflow, communication, service and patient outcomes. VetZ was founded in 1997 and headquartered in Isernhagen, Germany.

Buy -